Cited in Dalakas, Marinos C (08 September 2010). "Treatment and Management of Autoimmune Myopathies". In Bertorini, Tulio E. Neuromuscular Disorders. Elsevier Health Sciences. pp. 395—408. ISBN9781437703726:
Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K (March 1997). "Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study". Neurology. 48 (3): 712–716. doi:10.1212/wnl.48.3.712. PMID9065553. S2CID25118314.
Spector SA, Lemmer JT, Koffman BM, Fleisher TA, Feuerstein IM, Hurley BF, Dalakas MC (October 1997). "Safety and efficacy of strength training in patients with sporadic inclusion body myositis". Muscle & Nerve. 20 (10): 1242–1248. doi:10.1002/(sici)1097-4598(199710)20:10<1242::aid-mus6>3.3.co;2-x. PMID9324080.
Holton JL, Wedderburn LR, Hanna MG (29 May 2013). "Polymyositis, Dermatomyositis and Inclusion Body Myositis". In Goebel HH, Sewry CA, Weller RO (eds.). Muscle Disease: Pathology and Genetics. John Wiley & Sons. pp. 747–781. ISBN978-1-118-63549-0.
Bhai SF, Dimachkie MM, de Visser M (June 2022). "Is it really myositis? Mimics and pitfalls". Best Practice & Research. Clinical Rheumatology. 36 (2): 101764. doi:10.1016/j.berh.2022.101764. PMID35752578. S2CID250012951.
Baer AN, Wortmann RL (May 2013). "Noninflammatory myopathies". Rheumatic Disease Clinics of North America. 39 (2): 457–479. doi:10.1016/j.rdc.2013.02.006. PMID23597974.
Cited in Dalakas, Marinos C (08 September 2010). "Treatment and Management of Autoimmune Myopathies". In Bertorini, Tulio E. Neuromuscular Disorders. Elsevier Health Sciences. pp. 395—408. ISBN9781437703726:
Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K (March 1997). "Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study". Neurology. 48 (3): 712–716. doi:10.1212/wnl.48.3.712. PMID9065553. S2CID25118314.
Spector SA, Lemmer JT, Koffman BM, Fleisher TA, Feuerstein IM, Hurley BF, Dalakas MC (October 1997). "Safety and efficacy of strength training in patients with sporadic inclusion body myositis". Muscle & Nerve. 20 (10): 1242–1248. doi:10.1002/(sici)1097-4598(199710)20:10<1242::aid-mus6>3.3.co;2-x. PMID9324080.
Holton JL, Wedderburn LR, Hanna MG (29 May 2013). "Polymyositis, Dermatomyositis and Inclusion Body Myositis". In Goebel HH, Sewry CA, Weller RO (eds.). Muscle Disease: Pathology and Genetics. John Wiley & Sons. pp. 747–781. ISBN978-1-118-63549-0.
Bhai SF, Dimachkie MM, de Visser M (June 2022). "Is it really myositis? Mimics and pitfalls". Best Practice & Research. Clinical Rheumatology. 36 (2): 101764. doi:10.1016/j.berh.2022.101764. PMID35752578. S2CID250012951.
Baer AN, Wortmann RL (May 2013). "Noninflammatory myopathies". Rheumatic Disease Clinics of North America. 39 (2): 457–479. doi:10.1016/j.rdc.2013.02.006. PMID23597974.
Cited in Dalakas, Marinos C (08 September 2010). "Treatment and Management of Autoimmune Myopathies". In Bertorini, Tulio E. Neuromuscular Disorders. Elsevier Health Sciences. pp. 395—408. ISBN9781437703726:
Dalakas MC, Sonies B, Dambrosia J, Sekul E, Cupler E, Sivakumar K (March 1997). "Treatment of inclusion-body myositis with IVIg: a double-blind, placebo-controlled study". Neurology. 48 (3): 712–716. doi:10.1212/wnl.48.3.712. PMID9065553. S2CID25118314.
Holton JL, Wedderburn LR, Hanna MG (29 May 2013). "Polymyositis, Dermatomyositis and Inclusion Body Myositis". In Goebel HH, Sewry CA, Weller RO (eds.). Muscle Disease: Pathology and Genetics. John Wiley & Sons. pp. 747–781. ISBN978-1-118-63549-0.
Bhai SF, Dimachkie MM, de Visser M (June 2022). "Is it really myositis? Mimics and pitfalls". Best Practice & Research. Clinical Rheumatology. 36 (2): 101764. doi:10.1016/j.berh.2022.101764. PMID35752578. S2CID250012951.